Literature DB >> 25956872

Midfoot Charcot Neuroarthropathy in Patients With Diabetes: The Impact of Foot Ulceration on Self-Reported Quality of Life.

Katherine M Raspovic1, Kimberlee B Hobizal1, Bedda L Rosario1, Dane K Wukich2.   

Abstract

INTRODUCTION: Charcot neuroarthropathy (CN) and diabetic foot ulceration (DFU) are serious complications of diabetes mellitus (DM) that can result in infection, hospitalization, amputation, and have been shown to negatively affect quality of life (QOL). To the best of our knowledge, there are no studies in the literature that have specifically compared QOL in patients with diabetic CN without DFU to a group of patients with diabetic CN and concurrent DFU. The aim of this study was to compare self-reported assessments of QOL in patients with CN to a group of patients with CN and concomitant midfoot ulceration.
MATERIALS AND METHODS: We compared a group of 35 diabetic patients with midfoot CN and no ulcer to a group of 22 diabetic patients with midfoot CN and concurrent DFU. Self-reported outcome was assessed using the Medical Outcome Study Short Form 36 (SF-36) health survey and Foot and Ankle Ability Measure (FAAM).
RESULTS: No significant differences were found when comparing the 2 groups utilizing the SF-36 and FAAM with the exception that CN patients without foot ulcers had lower mean scores on the Bodily Pain Subscale. Both groups demonstrated negative impact on physical QOL and lower extremity function to a greater degree than mental QOL.
CONCLUSION: The presence of ulceration does not appear to significantly impact QOL in patients with CN when compared to patients with CN without ulceration. LEVELS OF EVIDENCE: Prognostic, Level III: Case control.
© 2015 The Author(s).

Entities:  

Keywords:  Charcot neuroarthropathy; SF-36; diabetic foot ulcer; quality of life

Mesh:

Year:  2015        PMID: 25956872      PMCID: PMC5663468          DOI: 10.1177/1938640015585957

Source DB:  PubMed          Journal:  Foot Ankle Spec        ISSN: 1938-6400


  19 in total

1.  Health-related quality of life of diabetic foot ulcer patients and their caregivers.

Authors:  M H Nabuurs-Franssen; M S P Huijberts; A C Nieuwenhuijzen Kruseman; J Willems; N C Schaper
Journal:  Diabetologia       Date:  2005-07-02       Impact factor: 10.122

2.  Self-reported quality of life and diabetic foot infections.

Authors:  Katherine M Raspovic; Dane K Wukich
Journal:  J Foot Ankle Surg       Date:  2014-08-13       Impact factor: 1.286

3.  Self-reported quality of life in patients with diabetes: a comparison of patients with and without Charcot neuroarthropathy.

Authors:  Katherine M Raspovic; Dane K Wukich
Journal:  Foot Ankle Int       Date:  2013-12-18       Impact factor: 2.827

4.  Quality of life in patients with diabetic foot ulcers.

Authors:  J W Meijer; J Trip; S M Jaegers; T P Links; A J Smits; J W Groothoff; W H Eisma
Journal:  Disabil Rehabil       Date:  2001-05-20       Impact factor: 3.033

5.  Health-related quality of life and self-esteem in patients with diabetic foot ulcers: results of a cross-sectional comparative study.

Authors:  Luiz Carlos de Meneses; Leila Blanes; Daniela Francescato Veiga; Heitor Carvalho Gomes; Lydia Masako Ferreira
Journal:  Ostomy Wound Manage       Date:  2011-03       Impact factor: 2.629

6.  Health-related quality of life of patients with diabetes and foot ulcers.

Authors:  Andrew R Evans; Michael S Pinzur
Journal:  Foot Ankle Int       Date:  2005-01       Impact factor: 2.827

7.  Validity of the Foot and Ankle Ability Measure (FAAM) in Diabetes Mellitus.

Authors:  Robroy L Martin; Dennis M Hutt; Dane K Wukich
Journal:  Foot Ankle Int       Date:  2009-04       Impact factor: 2.827

8.  Long-term outcome and quality of life in patients with Charcot foot.

Authors:  Toni-Karri Pakarinen; Heikki-Jussi Laine; Heikki Mäenpää; Pentti Mattila; Jorma Lahtela
Journal:  Foot Ankle Surg       Date:  2009-04-05       Impact factor: 2.705

Review 9.  Charcot arthropathy of the foot and ankle: modern concepts and management review.

Authors:  Dane K Wukich; Wenjay Sung
Journal:  J Diabetes Complications       Date:  2008-10-17       Impact factor: 2.852

10.  Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.

Authors:  Min-Woong Sohn; Rodney M Stuck; Michael Pinzur; Todd A Lee; Elly Budiman-Mak
Journal:  Diabetes Care       Date:  2009-10-13       Impact factor: 19.112

View more
  3 in total

Review 1.  Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis.

Authors:  Sean Michael Lanting; Tsz Long Chan; Sarah Louise Casey; Benjamin John Peterson; Vivienne Helaine Chuter
Journal:  J Foot Ankle Res       Date:  2022-03-01       Impact factor: 2.303

2.  Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Authors:  Rachel H Albright; Robert M Joseph; Dane K Wukich; David G Armstrong; Adam E Fleischer
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

3.  Foot ulcer recurrence, plantar pressure and footwear adherence in people with diabetes and Charcot midfoot deformity: A cohort analysis.

Authors:  R Keukenkamp; T E Busch-Westbroek; R Barn; J Woodburn; S A Bus
Journal:  Diabet Med       Date:  2020-11-03       Impact factor: 4.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.